Added to YB: 2024-04-01
Pitch date: 2024-03-30
SBFM [bullish]
Sunshine Biopharma, Inc.
-99.4%
current return
Author Info
@smantel is an ex-sell side analyst with a focus on fundamental research. Follow him on Twitter.
Company Info
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
Market Cap
$6.8M
Pitch Price
$222.60
Price Target
0.68 (-53%)
Dividend
N/A
EV/EBITDA
0.49
P/E
-0.55
EV/Sales
-0.07
Sector
Biotechnology
Category
growth
A Beacon of Opportunity: Sunshine Biopharma's Promising Future
SBFM: Generic drug co. trades at negative EV w/ $23M cash. Q4 rev $7.7M (+30.5% Q/Q), '23 rev $24M. Launching 32 new drugs in '24-'25. '25E rev $100M, EBITDA $16M, EPS $0.17. At 0 EV, price should be $0.21 (+160%). 1x '24 EV/S = $0.68 PT (+750%). Reverse split to 500K shares.
Read full article (2 min)